RECRUITING

Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes

Description

This study will assess changes in glycemic control in 40 patients with diabetes who undergo per-oral pyloromyotomy (POP) for medically refractory gastroparesis.

Conditions

Diabetes MellitusGastroparesis With Diabetes MellitusGastroparesis
Talk to us

Related Conditions:

Diabetes MellitusGastroparesis With Diabetes MellitusGastroparesis

Study Overview

On this page

Study Details

Study overview

This study will assess changes in glycemic control in 40 patients with diabetes who undergo per-oral pyloromyotomy (POP) for medically refractory gastroparesis.

Impact of Endoscopic Per-Oral Pyloromyotomy (POP) on Glycemic Control in Gastroparesis Patients With Poorly Controlled Diabetes Mellitus

Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes

Condition
Diabetes Mellitus
Intervention / Treatment

-

Contacts and Locations

Cleveland

Cleveland Clinic Foundation, Cleveland, Ohio, United States, 44195

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Patients 18 years of age and older
  • 2. Patients with gastroparesis with an average HbA1c\> 7.5% over the past 3 months
  • 3. Patient that have a diagnosis of gastroparesis established by documented delayed gastric emptying by either a wireless motility capsule study or a nuclear gastric emptying study, with no evidence of gastric obstruction.
  • 4. Patients are able to complete all study requirements
  • 1. Patients \<18 years of age
  • 2. Patients with gastroparesis with an average HbA1c\< 7.5% over the past 3 months
  • 3. Patients unable or refuse to complete the study requirements
  • 4. Patients who are unable or refuse to wear a CGM sensor
  • 5. Patients with insulin pumps
  • 6. Patients who already use a CGM

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Matthew Allemang,

Mathew Allemang, MD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

2026-06